Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126575922 | 12657592 | 2 | F | 20160815 | 20160816 | 20160819 | EXP | GB-JNJFOC-20160811306 | JANSSEN | 44.00 | YR | A | F | Y | 0.00000 | 20160819 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126575922 | 12657592 | 1 | PS | DARUNAVIR | DARUNAVIR | 1 | Oral | 800(UNITS UNSPECIFIED) | U | U | 21976 | 800 | MG | TABLETS | |||||
| 126575922 | 12657592 | 2 | SS | KIVEXA | ABACAVIR SULFATELAMIVUDINE | 1 | Oral | 600 MG/300 MG | U | 0 | UNSPECIFIED | ||||||||
| 126575922 | 12657592 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | 100 (UNITS UNSPECIFIED) | U | UNKNOWN | 0 | 100 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126575922 | 12657592 | 1 | Product used for unknown indication |
| 126575922 | 12657592 | 2 | Product used for unknown indication |
| 126575922 | 12657592 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126575922 | 12657592 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126575922 | 12657592 | Mental disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |